Seikagaku Corporation
JPX: 4548.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kenji Mizutani
- Employees
- 988
- Headquarters
- Tokyo, Japan
- IPO year
- 2004
- Market cap
- ¥38.9B
- Website
- https://www.seikagaku.co.jp
Loading 4548…
Loading profile data…Frequently asked questions about 4548
What does Seikagaku Corporation (4548.T) do?
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates in two segments, Pharmaceuticals and LAL. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of AR...
Where does 4548.T trade?
Seikagaku Corporation (4548.T) trades on the Tokyo Stock Exchange.
What sector is 4548.T in?
Seikagaku Corporation (4548.T) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Seikagaku Corporation?
Kenji Mizutani is the chief executive officer of Seikagaku Corporation (4548.T).
Where is Seikagaku Corporation headquartered?
Seikagaku Corporation is headquartered in Japan.
Does 4548.T pay a dividend?
Yes — Seikagaku Corporation (4548.T) paid a trailing twelve-month dividend of JPY 30.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4548.T go public?
Seikagaku Corporation (4548.T) completed its initial public offering in 2004.